Agallas Equities Launches $400 Million Real Estate Fund Focused on Transformative Development in the Dominican Republic

NEW YORK, Oct. 21, 2025 (GLOBE NEWSWIRE) — Agallas Equities LLC, a New York-based real estate investment and development firm, today announced the launch of its inaugural fund, the Agallas Equities Real Estate Fund I (The Fund), with a target capitalization of $400 million. The Fund will pursue a disciplined investment strategy focused exclusively on […]

CYIOS Corporation (OTC: CYIO) Announces Leadership Transition and Engages Artificial Intelligence (AI) and Software-as-a-Service (SaaS) advisors

(OtherOTC:CYIO),(OTC US:CYIO), MELBOURNE, Australia and PALM BEACH, Fla., Oct. 21, 2025 (GLOBE NEWSWIRE) — CYIOS Corporation (OTC: CYIO) today announced that David Lewis has stepped down from his roles with CYIOS, and as part of this transition, he has voluntarily agreed to return 16,560 Series D Preferred Shares to the Company, and cancel all outstanding

Sienna Announces The Opening of Its Long-Term Care Community Redevelopment in Brantford, Ontario

(TSX:SIA), MARKHAM, Ontario, Oct. 21, 2025 (GLOBE NEWSWIRE) — Sienna Senior Living Inc. (“Sienna” or the “Company“) (TSX: SIA) announced today that it has officially opened its Oakwood Commons Community in Brantford, Ontario, the Company's second long-term care redevelopment project completed in 2025. Oakwood Commons is a 160-bed long-term care community, replacing 122 older Class

Amaze Welcomes Global Gaming Influencer Mystic7 with the Launch of His Official Store

(NYSE MKT:AMZE), NEWPORT BEACH, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) — Amaze Holdings, Inc. (NYSE American: AMZE) (“Amaze”) a global leader in creator-powered commerce, today announced that leading gaming influencer Mystic7 has launched his official merchandise storefront on the Amaze platform. With a fanbase of more than 3 million followers across YouTube, X, and TikTok,

Vertex Announces CEO Retirement and Succession Plan

(NasdaqGM:VERX), Christopher Young to Succeed David DeStefano as Vertex's President and Chief Executive Officer Leadership Transition to Occur on November 10, 2025; David DeStefano to Serve as Non-Executive Chairperson Announces Preliminary Third Quarter Financial Results KING OF PRUSSIA, Pa., Oct. 21, 2025 (GLOBE NEWSWIRE) — Vertex, Inc. (NASDAQ: VERX) (“Vertex” or the “Company”), a leading

Pacira BioSciences Notified of Abbreviated New Drug Application Filing from The WhiteOak Group for EXPAREL(R)

(NASDAQ:PCRX), BRISBANE, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients today reported it has received a Paragraph IV Certification Notice Letter (PIV Notice) from The WhiteOak Group, a subsidiary of a small private

Planet Fitness Announces Partnership with Hockey Canada

(NYSE:PLNT), TORONTO, Oct. 21, 2025 (GLOBE NEWSWIRE) — Planet Fitness, one of the largest and fastest-growing franchisors and operators of fitness centers with more members than any other fitness brand, today announced a powerful multi-year partnership with Hockey Canada, diving into the Canadian culture of hockey and showcasing the importance of fitness and movement ahead

SEALSQ Joins the MIT Media Lab’s Global Community of Member Organizations

(NASDAQ:LAES), Geneva, Switzerland, Oct. 21, 2025 (GLOBE NEWSWIRE) — Exploring the intersection of security, sustainability, and human-centered innovation SEALSQ Corp (NASDAQ: LAES) (“SEALSQ” or “Company”), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, announced today that it has become a member of the MIT Media Lab,

Quoin Pharmaceuticals Announces U.S. FDA Grants Orphan Drug Designation for QRX003 in Netherton Syndrome

(NASDAQ:QNRX), Upon Approval of NDA Quoin Will Receive Seven Years Marketing Exclusivity for QRX003 in the US Orphan Drug Designation previously granted by the European Medicines Agency in May 2025 ASHBURN, Va., Oct. 21, 2025 (GLOBE NEWSWIRE) — Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (“Quoin” or the “Company”), a late clinical-stage specialty pharmaceutical company focused on

Defiance Launches QSU: The First 2X Long ETF for QuantumScape Corporation

(NYSE:QS), MIAMI, Oct. 21, 2025 (GLOBE NEWSWIRE) — Defiance ETFs is proud to announce the launch of the Defiance Daily Target 2X Long QS ETF (Ticker: QSU), expanding its suite of single-stock leveraged ETFs designed for active traders seeking amplified exposure to innovative, high-growth companies. The newest addition, QSU, is designed for traders who seek

Scroll to Top